NY Attorney General Letitia James sues developer David Roberts and his company for illegal land clearing and construction in the protected Pine Barrens.
The New York attorney general responded to Trump's executive order rolling back protections for transgender people.
New York AG Letitia James' lawsuit against Citibank for inadequate fraud safeguards proceeds after a judge's ruling.
Yellowstone Capital will cancel more than $534 million of outstanding debts owed by more than 18,000 small businesses.
Investigators for the state’s top law enforcement official have begun probing the practices of several organizations that serve as guardians to hundreds of New York’s most vulnerable residents. The inquiry follows a ProPublica investigation.
The settlement includes cancelling $534.5 million of debt owed by more than 18,000 small businesses nationwide.
A federal judge on Tuesday rejected Citigroup's bid to dismiss a lawsuit by New York Attorney General Letitia James claiming it failed to protect customers from online scammers and refused to reimburse customers who were victimized.
New York Attorney General Letitia James has announced a massive $1.065 billion judgment against Yellowstone Capital and its network of 25 lending companies
New York Attorney General Letitia James announced Thursday a new $7.5 billion settlement with Purdue Pharmaceuticals and the Sackler Family for their role in the ongoing US opioid crisis with the
Through a $1 billion settlement announced by New York Attorney General Letitia James, Yellowstone Capital agreed to wipe out more than $534 million in debt of its small-business clients. It resolves the attorney general's lawsuit alleging Yellowstone ran a large,
New York Attorney General Letitia James recently froze $2.2 million worth of crypto allegedly plundered in an employment scam.
New York State will gain up to $250 million from a $7.4 billion settlement with Purdue Pharma and the Sackler family, announced by Attorney General Letitia James. The Sacklers, linked to the opioid crisis through their drug OxyContin, will pay $6.5 billion over 15 years, while Purdue Pharma will contribute nearly $900 million.